96 related articles for article (PubMed ID: 1321935)
1. Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression.
Schatz AR; Kessler FK; Kaminski NE
Life Sci; 1992; 51(6):PL25-30. PubMed ID: 1321935
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
[TBL] [Abstract][Full Text] [Related]
4. The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes.
Little PJ; Martin BR
Life Sci; 1991; 48(12):1133-41. PubMed ID: 1848340
[TBL] [Abstract][Full Text] [Related]
5. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
7. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
Hillard CJ; Bloom AS; Houslay MD
Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
[TBL] [Abstract][Full Text] [Related]
8. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
9. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
Kaminski NE; Abood ME; Kessler FK; Martin BR; Schatz AR
Mol Pharmacol; 1992 Nov; 42(5):736-42. PubMed ID: 1279376
[TBL] [Abstract][Full Text] [Related]
10. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function.
Schatz AR; Koh WS; Kaminski NE
Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537
[TBL] [Abstract][Full Text] [Related]
11. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
Howlett AC; Scott DK; Wilken GH
Biochem Pharmacol; 1989 Oct; 38(19):3297-304. PubMed ID: 2554920
[TBL] [Abstract][Full Text] [Related]
12. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.
McKallip RJ; Lombard C; Martin BR; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2002 Aug; 302(2):451-65. PubMed ID: 12130702
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
15. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
16. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol.
Loveless SE; Harris LS; Munson AE
J Immunopharmacol; 1981-1982; 3(3-4):371-83. PubMed ID: 6290570
[TBL] [Abstract][Full Text] [Related]
17. Possible role of prostaglandins in the effects of the cannabinoids on adenylate cyclase activity.
Hillard CJ; Bloom AS
Eur J Pharmacol; 1983 Jul; 91(1):21-7. PubMed ID: 6311573
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.
Howlett AC
Life Sci; 1984 Oct; 35(17):1803-10. PubMed ID: 6090851
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
Herring AC; Koh WS; Kaminski NE
Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
[TBL] [Abstract][Full Text] [Related]
20. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
Sánchez C; Velasco G; Guzmán M
Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
